Workflow
万邦医药(301520.SZ)：不涉及自主研发抗癌药物
Anhui Wanbang Pharmaceutical Technology Anhui Wanbang Pharmaceutical Technology (SZ:301520) Ge Long Hui·2025-10-16 09:40

Core Viewpoint - Wanbang Medicine (301520.SZ) is identified as a CRO (Contract Research Organization) that specializes in providing professional pharmaceutical research outsourcing services to pharmaceutical companies and research institutions, specifically in clinical trial research services for cancer patients' medications [1] Company Overview - The company does not engage in the independent development of anti-cancer drugs, focusing solely on providing outsourced research services [1]